Search

everythinglearnresearchcommunity

for

Search:↓

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Fever and rash can be early signs of lupus.

The document explains various skin conditions and their treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Skin conditions in multiple myeloma patients vary with the timing of bone marrow transplants.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A woman with lupus and severe nerve damage improved with specific treatments.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

VKHD and sarcoidosis may share a common cause.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.